Orikine Bio
SpainEntry
2023
Hold
3yr
Status
Active
Who owns Orikine Bio?
Orikine Bio is currently owned by Asabys Partners through Sabadell Asabys Health Innovation Investments II (2023 vintage), since 2023. Across its history, Orikine Bio has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Asabys PartnersSabadell Asabys Health Innovation Investments II · 2023 · Life Sciences VC
2 ownership periods · full history below
Key facts
HQSpain
SectorBiotech
Ownership history
2 ownership periods
Active
Asabys PartnersActive
2023 · present(3yr) · Sabadell Asabys Health Innovation Investments II · 2023 · Life Sciences VC
AdBio PartnersActive
2026 · present(<1yr) · AFB Fund II · 2021 · VC
More from Sabadell Asabys Health Innovation Investments II
Other portfolio companies in the same fund.
France
BelgiumMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USTrack Orikine Bio
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Orikine Bio?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Orikine Bio.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue